Prospective multi-center randomized double-blind trial to assess the effectiveness and safety of 12 vs 30 months of dual antiplatelet therapy (DAPT) in subjects undergoing percutaneous coronary intervention (PCI) with either drug-eluting (DES) or bar

Project: Non Profit

Project Details

StatusActive
Effective start/end date6/30/10 → 11/14/37

Funding

  • Harvard Clinical Research Institute